These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Rubinstein E; Lavine JE; Schwimmer JB Semin Liver Dis; 2008 Nov; 28(4):380-5. PubMed ID: 18956294 [TBL] [Abstract][Full Text] [Related]
65. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Day CP Gastroenterology; 2005 Jul; 129(1):375-8. PubMed ID: 16012969 [No Abstract] [Full Text] [Related]
66. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098 [TBL] [Abstract][Full Text] [Related]
67. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. Gan SK; Adams LA; Watts GF Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882 [TBL] [Abstract][Full Text] [Related]
68. Definition and natural history of metabolic steatosis: histology and cellular aspects. Paradis V; Bedossa P Diabetes Metab; 2008 Dec; 34(6 Pt 2):638-42. PubMed ID: 19195624 [TBL] [Abstract][Full Text] [Related]
69. Epidemiology and natural history of NAFLD and NASH. Ong JP; Younossi ZM Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968 [TBL] [Abstract][Full Text] [Related]
70. Nonalcoholic fatty liver disease as a complication of insulin resistance. Abdelmalek MF; Diehl AM Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913 [TBL] [Abstract][Full Text] [Related]
71. Update on non-alcoholic fatty liver disease in children. Papandreou D; Rousso I; Mavromichalis I Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148 [TBL] [Abstract][Full Text] [Related]